Cointime

NMD Pharma

company

About

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

  • 11 - 50

Highlights

Total Funding Amount
€75.70M
Funding Rounds
3
Investors
1
Investments
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€35M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify and develop first-class therapeutics for neuromuscular diseases that are unmet medically.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€75.70M
NMD Pharma has raised a total of €75.70M in funding over 2 rounds. Their latest funding was raised on Feb 15, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 15, 2022 Series Unknown €35M 1 — — Detail
Mar 23, 2018 Series A €38M 1 — — Detail
Jul 1, 2016 Series Unknown €2.70M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
NMD Pharma has made 1 investments. Their most recent investment was on Oct 1, 2013, when Casetext raised $1.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 1, 2013 Casetext
Seed $1.80M Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
—
1
NMD Pharma is funded by 1 investors. Lundbeckfonden Emerge are the most recent investors.
Investor Name Lead Investor Funding Round
Lundbeckfonden Emerge — Series Unknown
Cointime
Content
Company